Dr. Gradishar on Endocrine Therapy in Early Stage Disease
January 10th 2014William J. Gradishar, MD, Professor in Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, discusses the treatment of early stage breast cancer with endocrine therapy and considerations following resistance.
Read More
Dr. William Gradishar Reviews the Eribulin 301 Study
February 8th 2013William J. Gradishar, MD, from the Northwestern University Feinberg School of Medicine, describes results from the 301 Study that compared eribulin mesylate to capecitabine for locally advanced or metastatic breast cancer.
Read More